Obstetrics & Gynecology Doctors in Bayside, NY Accepting Medicare

6 Obstetrics & Gynecology doctors found. Showing 1 - 6

Meir Greenberg, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 21410 24th Ave, Bayside, NY 11360 Phone: 718-224-5800

Ilia E. Calluzzo, M.D, Obstetrics & Gynecology - Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3629 Bell Blvd, Bayside, NY 11361 Phone: 718-224-5800

Dr. Gilad Greenberg, M.D. Obstetrics & Gynecology - Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3629 Bell Blvd, Bayside, NY 11361 Phone: 718-224-5800

Dr. Randi Rothstein, M.D. Obstetrics & Gynecology - Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3629 Bell Blvd, Bayside, NY 11361 Phone: 718-224-5800

Dr. Christine Melgar, M.D. Obstetrics & Gynecology - Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3629 Bell Blvd, Bayside, NY 11361 Phone: 718-224-5800

Dr. Richard Herzog, M.D. Obstetrics & Gynecology - Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3629 Bell Blvd, Bayside, NY 11361 Phone: 718-224-5800

News Archive

Symphogen's Sym004 Phase 1 trial data on advanced solid tumors presented at ASCO 2011

Symphogen announced today preliminary primary endpoint data on 12 of 20 patients enrolled in the first Phase 1 clinical trial with their lead cancer compound, Sym004.

European Bioinformatics Institute drives genomics research with GÉANT

The European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI), which hosts the world's largest public collection of molecular biology databases, is using the pan-European GÉANT research network and JANET, the UK research network, to help biologists share vital data across the globe.

Preliminary data of BIBW 2992 in head and neck cancer, NSCLC to be presented at ASCO 2010

Boehringer Ingelheim will announce preliminary data in the areas of head and neck cancer and non-small cell lung cancer for one of the company's investigational compounds, BIBW 2992. These data will be presented at the 2010 Annual Meeting of the American Society of Clinical Oncology annual meeting in Chicago.

Patients switching to Victoza experience further reductions in A1c and weight loss

Diabetes Care published online the results of the Novo Nordisk LEAD™ 6 extension study, which evaluated the efficacy and safety of switching from exenatide, which is taken twice a day, to once-daily Victoza®. Results show that when added to oral antidiabetes drugs, patients who switched from exenatide to Victoza experienced further reductions in A1c and weight loss.

Two-day international Osteoarthritis Summit to be held in June 2011

Hospital for Special Surgery (HSS) plans to host a two-day international Osteoarthritis Summit in June 2011. The Hospital, internationally recognized for its leadership in the fields of orthopedics and rheumatology, will bring together, for the first time, a truly comprehensive multidisciplinary group of world renowned scientists, thought-leaders and industry representatives from the United States, Canada, and Europe, to discuss all aspects of OA and develop a consensus document on future directions for OA research, prevention and treatment.

Read more Medical News

› Verified 6 days ago